Women see more adverse events with chemotherapy and newer cancer treatments, study finds

Research has long shown that women are more likely than men to have severe reactions to chemotherapy treatments. At the same time, emerging evidence suggests that women also experience greater toxicity with targeted therapies and immunotherapies, which aim in part to mitigate the inherent toxicities of chemotherapy.